Cancellation of state registration. Nebivolol Stade®

September 29, 2017
Active substances:
ICD-10:
IX.I10-I15.I10    Essential [primary] hypertension
IX.I20-I25.I20    Angina pectoris [angina pectoris]
Nebivolol, hypertension, essential hypertension, angina pectoris, treatment of angina pectoris

The Ministry of Health of the Russian Federation in accordance with Article 32 of the Federal Law of 12.04.2010 No. 61-FZ "On the circulation of medicinal products" decided to abolish state registration and exclusion from the state register of medicinesfor the medical use of the medicinal product (registration certificate LGG001083 dated 02.11.2011 issued by STADA Artsnaymittel AG, Germany):

Nebivolol Stade® (trade name of the medicinal product)

Nebivolol (international non-proprietary or grouping or chemical name)

tablets, 5 mg (dosage form, dosage)

STADA Arzneimittel AG, Germany Stadastrasse 2-18, D-61118 Bad Vilbel, Germany (name and address of the location of the manufacturer of the medicinal product)

on the basis of filing by an authorized legal entity of Nizhpharm, an application for the cancellation of the state registration of a medicinal product.